deltatrials
Completed PHASE1 INTERVENTIONAL 5-arm NCT02177513

Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cannabis Use
Interventions 6.9% cannabis oral Oral Cannabis + Placebo Placebo + Inhaled Cannabis Placebo + Placebo Placebo + Smoked Cannabis
Updated 23 times since 2017 Last updated: Dec 13, 2019 Started: Jun 14, 2014 Primary completion: Apr 27, 2016 Completion: Apr 27, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02177513, this PHASE1 trial focuses on Cannabis Use and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 23 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2018 · 15 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

23 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE1

  5. Dec 2019 — Jan 2020 [monthly]

    Completed PHASE1

▶ Show 18 earlier versions

  1. Nov 2019 — Dec 2019 [monthly]

    Completed PHASE1

  2. Oct 2019 — Nov 2019 [monthly]

    Completed PHASE1

  3. Sep 2019 — Oct 2019 [monthly]

    Completed PHASE1

  4. Jul 2019 — Sep 2019 [monthly]

    Completed PHASE1

  5. Jun 2019 — Jul 2019 [monthly]

    Completed PHASE1

  6. May 2019 — Jun 2019 [monthly]

    Completed PHASE1

  7. Apr 2019 — May 2019 [monthly]

    Completed PHASE1

  8. Mar 2019 — Apr 2019 [monthly]

    Completed PHASE1

  9. Feb 2019 — Mar 2019 [monthly]

    Completed PHASE1

  10. Dec 2018 — Feb 2019 [monthly]

    Completed PHASE1

  11. Nov 2018 — Dec 2018 [monthly]

    Completed PHASE1

  12. Oct 2018 — Nov 2018 [monthly]

    Completed PHASE1

  13. Sep 2018 — Oct 2018 [monthly]

    Completed PHASE1

  14. Aug 2018 — Sep 2018 [monthly]

    Completed PHASE1

  15. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE1

  16. May 2018 — Jun 2018 [monthly]

    Completed PHASE1

  17. Feb 2017 — May 2018 [monthly]

    Completed PHASE1

  18. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute on Drug Abuse (NIDA)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations